UKSIF London Analyst Conference 2020
On Thursday 26 November, Damiano de Felice, Director of Strategy at the Access to Medicine Foundation, will chair a panel discussion on ‘Big Pharma: Affordability and Access to Medicines’ at the UKSIF London Analyst Conference 2020. The event will explore key issues related to affordability and access to medicine for investors in pharmaceutical companies.
Damiano will discuss the materiality of global health topics such as affordability in high-income countries, access to medicines in emerging markets, and how and where pharmaceutical companies are making progress.
The UKSIF London Analyst Conference is designed in collaboration with the UKSIF Analyst Committee and follows a member-led agenda focused on issues that provide practical support to advance ESG integration.
- Nikki Gwilliam-Beeharee, Director of ESG Research, Invseco
- Claus Runge, Senior Vice President, Global Head of Market Access, Public Affairs & Sustainability, Bayer Pharmaceuticals
- (Chair) Damiano de Felice, Director of Strategy, Access to Medicine Foundation
As of November 2020, 100+ investors – together managing assets of more than USD 15 trillion – have signed the Access to Medicine Index Investor Statement and committed to using the research of the Access to Medicine Foundation in their investment analysis and engagements with companies. Find out more about our work with investors here.